Inventor · disambiguated record
Ashit K. Ganguly
Also filed as: GANGULY ASHIT · GANGULY ASHIT K · GANGULY ASHIT KUMAR
106 granted patents·5 pending applications·2,845 citations·filing 1975–2020
99Inventor score
Files withSCHERING CORP102DENDREON CORP5BRISTOL MYERS SQUIBB CO2SAKSENA ANIL K1SCHERING PLOUGH ANIMAL HEALTH1
Top patents by PatentIndex Score
111 records- 0198US6838475B2Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jan 4, 2005·121 cites·43 claims
- 0297US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0397US5272167APharmaceutically active compoundsSCHERING CORP·Filed 1990·Granted Dec 21, 1993·104 cites·6 claims
- 0497US5089496ABenzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergiesSCHERING CORP·Filed 1989·Granted Feb 18, 1992·138 cites·49 claims
- 0596US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 0696US4076711ATriazolo [4,5-d]-pyrimidinesSCHERING CORP·Filed 1976·Granted Feb 28, 1978·55 cites·6 claims
- 0795US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 0895US6846802B2Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moietiesSCHERING CORP·Filed 2001·Granted Jan 25, 2005·124 cites·21 claims
- 0995US5459144APharmaceutically active compoundsSCHERING CORP·Filed 1993·Granted Oct 17, 1995·64 cites·3 claims
- 1094US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 1194US6914122B2Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moietiesSCHERING CORP·Filed 2001·Granted Jul 5, 2005·89 cites·36 claims
- 1294US6432959B1Inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 1999·Granted Aug 13, 2002·75 cites·6 claims
- 1394US5661151ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Aug 26, 1997·69 cites·13 claims
- 1494US4851423APharmaceutically active compoundsSCHERING CORP·Filed 1986·Granted Jul 25, 1989·86 cites·21 claims
- 1594US4826853A6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of useSCHERING CORP·Filed 1986·Granted May 2, 1989·90 cites·29 claims
- 1693US6403564B1Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 1999·Granted Jun 11, 2002·122 cites·2 claims
- 1793US6277830B15′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferonSCHERING CORP·Filed 1999·Granted Aug 21, 2001·120 cites·43 claims
- 1893US5750532APharmaceutically active compoundsSCHERING CORP·Filed 1995·Granted May 12, 1998·68 cites·3 claims
- 1993US4530793AProcesses for the production of penemsSCHERING CORP·Filed 1982·Granted Jul 23, 1985·30 cites·3 claims
- 2092US5104876ABenzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of useSCHERING CORP·Filed 1989·Granted Apr 14, 1992·39 cites·13 claims
- 2192US5039676ATri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereofSCHERING CORP·Filed 1990·Granted Aug 13, 1991·54 cites·12 claims
- 2292US5034531AFused polycyclic pyranyl compounds as antiviral agentsSCHERING CORP·Filed 1988·Granted Jul 23, 1991·37 cites·5 claims
- 2391US5116840APolycyclic quinoline, naphthyridine and pyrazinopyridine derivativesSCHERING CORP·Filed 1990·Granted May 26, 1992·45 cites·8 claims
- 2491US4443373AProcess for the production of antibiotic penemsSCHERING CORP·Filed 1982·Granted Apr 17, 1984·27 cites·16 claims
- 2589USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 2689US6096757AMethod for treating proliferative diseasesSCHERING CORP·Filed 1998·Granted Aug 1, 2000·91 cites·21 claims
- 2787US5714490ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Feb 3, 1998·37 cites·20 claims
- 2886US6333333B1Methods for treating proliferative diseasesSCHERING CORP·Filed 2000·Granted Dec 25, 2001·22 cites·24 claims
- 2986US5696267ASubstituted oximes, hydrazones and olefins as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Dec 9, 1997·70 cites·23 claims
- 3084US5516784AAnti-HIV (AIDS) agentsSCHERING CORP·Filed 1992·Granted May 14, 1996·26 cites·18 claims
- 3180US5693626ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 2, 1997·24 cites·11 claims
- 3279US6924270B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2001·Granted Aug 2, 2005·11 cites·16 claims
- 3379US5972331ACrystalline interferon alpha for pulmonary delivery and method for producing the sameSCHERING CORP·Filed 1995·Granted Oct 26, 1999·65 cites·19 claims
- 3479US5446069ABenzoalkano compounds and their use for tracting hyperproliferative diseasesSCHERING CORP·Filed 1993·Granted Aug 29, 1995·16 cites·31 claims
- 3579US5439916APolycyclic quinoline, naphthyridine and pyrazinopyridine derivativesSCHERING CORP·Filed 1990·Granted Aug 8, 1995·19 cites·11 claims
- 3679US5403937AProcess for preparing intermediates for the synthesis of antifungal agentsSCHERING CORP·Filed 1993·Granted Apr 4, 1995·21 cites·16 claims
- 3779US5126352APolycyclic quinoline, naphthyridine and pyrazinopyridine derivativesSCHERING CORP·Filed 1990·Granted Jun 30, 1992·19 cites·13 claims
- 3879US4435412A5R,6S,8R-2-(1-Methyl-2-imidazolylmethylthio)-6-(1-hydroxyethyl)penem-3-carboxylic acidSCHERING CORP·Filed 1983·Granted Mar 6, 1984·11 cites·15 claims
- 3977US7115578B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2004·Granted Oct 3, 2006·8 cites·7 claims
- 4076US4999428AProcess for preparing cyclopentyl purine derivativesSCHERING CORP·Filed 1989·Granted Mar 12, 1991·12 cites·14 claims
- 4175US4279896ANovel 20-imino macrolide antibacterial agentsSCHERING CORP·Filed 1980·Granted Jul 21, 1981·14 cites·57 claims
- 4275US3975372APreparation of 12,13-desepoxy-12,13-dehydrorosamicinSCHERING CORP·Filed 1975·Granted Aug 17, 1976·12 cites·7 claims
- 4374US6673775B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2001·Granted Jan 6, 2004·4 cites·38 claims
- 4474US5703079ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 30, 1997·16 cites·9 claims
- 4574US4272439A6-(Substituted-hydroxymethylene penams)SCHERING CORP·Filed 1978·Granted Jun 9, 1981·12 cites·4 claims
- 4673US4283531ASynthesis of β-lactams having a substituted hydroxymethylene group at the position α to the lactam carbonyl groupSCHERING CORP·Filed 1979·Granted Aug 11, 1981·7 cites·14 claims
- 4771US4584133AProcess for the production of penemsSCHERING CORP·Filed 1983·Granted Apr 22, 1986·12 cites·1 claims
- 4871US4503064AOxime substituted penemsSCHERING CORP·Filed 1984·Granted Mar 5, 1985·6 cites·17 claims
- 4970US5710154ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Jan 20, 1998·13 cites·20 claims
- 5070US4559333AHydrazone substituted penemsSCHERING CORP·Filed 1984·Granted Dec 17, 1985·7 cites·10 claims
Showing the top 50 of 111 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →